FDA Medical Device Cybersecurity Labeling Requirements

Updated December 26, 2025

In today’s connected healthcare environment, a medical device’s labeling is no longer just about operating instructions - it’s a critical cybersecurity safeguard. Without clear, complete, and accurate labeling, healthcare providers may unknowingly deploy devices with insecure settings, fail to apply necessary updates, or overlook known vulnerabilities.

The FDA’s 2025 guidance, Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions, makes this point clear: inadequate cybersecurity labeling can render a device misbranded under the FD&C Act (502(f), 502(j)) and put patient safety at risk. For manufacturers, proper cybersecurity labeling is both a compliance requirement and a trust-building tool for hospitals, clinicians, and patients.

Key Takeaways

• Identify all communication interfaces and exposure points.
• Summarize third-party software components; provide full SBOM access.
• Furnish step-by-step secure configuration guidance.
• Detail update/patch management procedures and expectations.
• Disclose known vulnerabilities and compensating controls.
• Treat cybersecurity labeling as a living document.

Table of Contents

• Key Takeaways
• FDA Cybersecurity Labeling Requirements and What to Include
• Recommended additions that improve usability and reduce postmarket friction
• Wrap-Up: Turn Labeling Into a Deployment Asset
• How Blue Goat Cyber Helps
• FDA Medical Device Cybersecurity Labeling FAQs

Why This Matters

The FDA's February 3, 2026 final guidance "Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions" makes cybersecurity labeling a required deliverable in eSTAR v7.0 - not an optional appendix. Submissions that lack the labeling content reviewers expect (security features, default configurations, network requirements, SBOM access, vulnerability disclosure contact, end-of-support dates) routinely draw an Additional Information letter, and AI cycles cost roughly 6-12 weeks each.

Beyond the submission, hospital security teams now use cybersecurity labeling as procurement gate criteria. The Health Sector Coordinating Council's Medical Device and Health IT Joint Security Plan (JSP) and the MDS2 v2025 form both reference label-equivalent content, and IDNs increasingly refuse to onboard devices whose labeling does not answer those questions. Weak labeling has become a measurable revenue obstacle, not just a regulatory one.

The standards stack here is consistent: AAMI TIR57 for labeling content, AAMI SW96 (FDA Recognized Consensus Standard 13-122) for the security risk file the label has to be consistent with, IEC 81001-5-1 for the lifecycle that produces the label, and Section 524B of the FD&C Act for the patchability and vulnerability disclosure obligations the label has to disclose. Treating labeling as design-controlled engineering output, not marketing copy, is what keeps it defensible.

FDA Cybersecurity Labeling Requirements and What to Include

Section VI.A of the FDA’s Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (2025) describes what the FDA expects manufacturers to communicate through cybersecurity labeling. In plain terms, your labeling should provide the intended users (e.g., hospital IT/security teams, HTM/biomed, and healthcare providers) with device-specific, actionable information they need to securely install, configure, operate, maintain, and decommission the device across its lifecycle.

FDA VI.A baseline: the core elements your labeling should cover

Below is a practical checklist you can use to align with the FDA’s labeling expectations while keeping the content usable for real-world deployment.

1) Communication interfaces and system exposure

Identify every wired and wireless interface, as well as logical interfaces, including those that are disabled by default or planned for future activation. Include:

• Physical interfaces (e.g., Ethernet, USB, serial)
• Wireless interfaces (e.g., Wi‑Fi, Bluetooth)
• Logical interfaces and services (e.g., APIs, cloud connections, remote service channels)
• Protocols/services used (e.g., TCP/IP, SNMP), and any required ports/services

Why it matters: Healthcare IT teams need to understand the device’s “attack surface” to plan segmentation, firewall rules, and monitoring.

Best-practice format: Add a simple “Interfaces & Services” table with columns like: Interface, Purpose, Protocol, Port(s), On by default (Y/N), Can be disabled (Y/N), Notes/constraints.

2) Third-party software components (SBOM-related summary)

Provide a labeling-level summary of key third-party components and versions (OS, libraries, frameworks, middleware), and indicate where authorized users can obtain the full SBOM. Include:

• Major third-party components and version identifiers
• A pointer to the complete SBOM location/process (portal, customer request workflow, etc.)
• Any constraints (e.g., “SBOM provided to authorized users under support agreement”)

Why it matters: When a new vulnerability/CVE hits a standard component, hospitals need to quickly determine whether they’re exposed and what to do next.

Tip: Keep labeling concise. Labeling can summarize “what’s important for users,” while the full SBOM remains the authoritative, detailed artifact.

3) Secure configuration and hardening instructions

Give step-by-step, device-specific instructions for secure deployment in the intended environment. Include:

• Authentication requirements (password policy, MFA expectations if supported)
• Authorization and user roles (e.g., RBAC setup, least privilege guidance)
• Certificate/key management expectations (where applicable)
• Network guidance (segmentation recommendations, allowed inbound/outbound flows)
• Which services/ports can be safely disabled
• Secure defaults vs. what must be changed on first use

Why it matters: Misconfiguration is one of the most common real-world causes of security issues. Clear instructions reduce both risk and support burden.

Best-practice format: A “Secure Setup Checklist” (numbered steps) plus an appendix/reference table (ports, protocols, firewall rules, required domains/endpoints, etc.).

4) Update and patch management procedures

Explain how users maintain device security over time-without relying on guesswork. Include:

• How updates are delivered (OTA, local media, vendor remote service, etc.)
• How authenticity/integrity is verified (e.g., digital signatures, secure boot checks)
• Expected downtime and any workflow planning considerations
• Failure handling and rollback steps (what to do if an update fails)
• Any user responsibilities vs. vendor responsibilities

Why it matters: Hospitals must maintain security while minimizing disruptions to clinical care. A clear update “runbook” prevents delays and unsafe workarounds.

5) Known vulnerabilities, residual risk, and compensating controls

If there are risks that cannot be fully mitigated without compromising clinical performance, disclose them clearly and provide practical mitigation strategies to address these risks. Include:

• A plain description of what remains and why
• The potential impact in user-relevant terms
• Compensating controls that the user can apply (segmentation, monitoring, access restrictions, configuration changes)
• Any operational constraints or “do not do this” warnings

Why it matters: Transparency enables users to manage risk responsibly and demonstrates a mature approach to risk communication.

Recommended additions that improve usability and reduce postmarket friction

See also: SPDF and IEC 62304 Mapping: FDA Cyber Guide, FDA Penetration Testing Requirements for Medical Devices, and Letter to File vs New 510(k) for Cybersecurity Changes.

The items below often make cybersecurity labeling far more helpful in practice-and can reduce review churn, customer confusion, and support escalations.

Logging and monitoring capabilities

Include:

• What security logs/events are available
• Log format and how to export/forward (e.g., SIEM integration options)
• Retention duration and any storage limits
• Time synchronization requirements (NTP guidance)

Why it matters: Without logs, hospitals can’t investigate incidents or meet internal security policies.

End-of-support and secure decommissioning guidance

Include:

• End-of-support policy basics (where users find current status)
• Secure retirement steps (data deletion, account removal, key/cert handling)
• Disposal/sanitization expectations where applicable

Why it matters: Lifecycle security includes “safe offboarding,” not just secure deployment.

Treat cybersecurity labeling as a living artifact

Plan to update labeling when:

• New vulnerabilities affect included components
• Update mechanisms or supported configurations change
• Older protocols/OS/platforms are deprecated
• Your recommended secure configuration evolves based on field learnings

This “living document” approach helps keep users secure and demonstrates ongoing cybersecurity maturity across the total product lifecycle.

How to Write Cybersecurity Labeling Hospitals Can Actually Use

Cybersecurity labeling should be written for individuals who deploy and maintain devices in real clinical environments, including hospital IT/security teams, HTM/biomed personnel, and service personnel. To make labeling usable (and defensible), focus on clarity and specificity:

• Write in tasks, not generalities: “Configure TLS 1.2+” beats “use secure protocols.”
• Define minimum secure settings: password length/complexity, MFA expectations (if supported), encryption standards, and segmentation guidance.
• Use quick-reference formats: tables for ports/protocols, firewall rules, required endpoints/domains, and a secure setup checklist.
• Include a simple network diagram: trust boundaries and data flows help teams deploy securely.
• Keep it consistent with SPDF/QMS artifacts: labeling should align with your threat model, risk controls, SBOM, and update strategy.

Common Cybersecurity Labeling Mistakes (and How to Avoid Them)

• Mistake: Documenting only “active today” interfaces

Fix: Include disabled-by-default and future-enabled interfaces to avoid surprises in the field.

• Mistake: Hiding third-party and cloud dependencies

Fix: Provide an SBOM summary and clearly state where the full SBOM can be obtained.

• Mistake: Vague hardening guidance

Fix: Provide step-by-step secure configuration instructions and minimum requirements.

• Mistake: Unclear update/patch behavior

Fix: Explain delivery method, integrity checks, downtime expectations, and rollback steps.

• Mistake: No residual-risk disclosure

Fix: Communicate known issues and compensating controls in user-relevant language.

• Mistake: Labeling drifts from SPDF evidence

Fix: Ensure the story aligns with what you submit to the FDA and what you provide to customers.

Wrap-Up: Turn Labeling Into a Deployment Asset

FDA cybersecurity labeling is more than a submission requirement-it’s the operational guide customers use to deploy, maintain, and retire devices securely. The strongest labeling is device-specific, actionable, aligned to your SPDF, and kept current as vulnerabilities, configurations, and support policies evolve.

Key takeaways:

• Document all interfaces and exposure.
• Provide an SBOM summary and access path to the full SBOM.
• Give step-by-step secure configuration guidance.
• Make patching predictable (including rollback).
• Be transparent about residual risk and compensating controls

How Blue Goat Cyber Helps

At Blue Goat Cyber, we specialize in guiding medical device manufacturers through FDA-compliant cybersecurity labeling, from initial design through post-market updates. We combine deep regulatory expertise with real-world security engineering to ensure your labeling meets or exceeds FDA requirements, protects patient safety and data integrity, and supports your market access and reputation.

To ensure your device labeling is accurate, compliant, and trusted by healthcare providers, contact us today to schedule a consultation.

FAQ

What does the FDA expect to see in medical device cybersecurity labeling?

The FDA generally expects device-specific, actionable instructions that help intended users install, configure, operate, maintain, and decommission the device securely. This typically includes: interfaces/exposure, SBOM-related component transparency, secure configuration guidance, update/patch procedures, and residual risk/compensating controls.

What should be included in cybersecurity labeling?

According to the February 3, 2026 FDA guidance, cybersecurity labeling should include: all communication interfaces (wired, wireless, cloud, APIs); third-party software components and versions (SBOM summary); secure configuration instructions for integration into the intended environment; update and patch procedures, including verification methods; and known, unmitigated vulnerabilities with mitigation guidance.

Do we need to publish the full SBOM in the labeling?

Not usually. A strong approach is to include an SBOM-level summary (key third-party components and version identifiers) along with a clear method for customers/authorized users to obtain the full SBOM (e.g., portal, support request process, customer package). The goal is to conduct a fast vulnerability impact assessment-without overwhelming the IFU with pages of component detail.

Why is cybersecurity labeling important for medical devices?

Cybersecurity labeling is crucial because it provides healthcare providers with the necessary information to securely deploy and manage medical devices. Without clear labeling, devices may be misconfigured, vulnerable to attacks, or fail to receive critical updates, potentially compromising patient safety and data integrity.

How often should cybersecurity labeling be updated?

Cybersecurity labeling should be updated when new vulnerabilities affect included components, update mechanisms or supported configurations change, older protocols/OS/platforms are deprecated, or recommended secure configurations evolve based on field learnings. This ensures the information remains current and useful.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.